R.L. Murphy
Northwestern University
Chicago
USA
Name/email consistency: high
- Introduction. Murphy, R.L. Clin. Infect. Dis. (2000)
- Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. Murphy, R.L., Gulick, R.M., DeGruttola, V., D'Aquila, R.T., Eron, J.J., Sommadossi, J.P., Currier, J.S., Smeaton, L., Frank, I., Caliendo, A.M., Gerber, J.G., Tung, R., Kuritzkes, D.R. J. Infect. Dis. (1999)
- Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1. Murphy, R.L., Sommadossi, J.P., Lamson, M., Hall, D.B., Myers, M., Dusek, A. J. Infect. Dis. (1999)
- Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks. Murphy, R.L. Antivir. Ther. (Lond.) (1999)
- Stavudine-based multiple agent combinations: initial studies and ongoing comparative trials. Murphy, R.L. Antivir. Ther. (Lond.) (1998)